Daiichi Sankyo Co. Ltd. | Ownership
Companies that own Daiichi Sankyo Co. Ltd.
Capital Research & Management Co. (Global Investors)
42,458,200
5.99%
16,200,000
0.3%
06/30/2018
Asset Management One Co., Ltd.
23,607,300
3.33%
-7,372,130
0.67%
06/15/2018
Nomura Asset Management Co., Ltd.
22,510,899
3.18%
228,474
0.5%
07/31/2018
BlackRock Fund Advisors
22,136,309
3.12%
2,759,294
0.04%
08/15/2017
The Vanguard Group, Inc.
15,796,288
2.23%
21,700
0.02%
07/31/2018
Capital Research & Management Co. (World Investors)
13,886,000
1.96%
-7,120,000
0.08%
06/30/2018
BlackRock Japan Co., Ltd.
12,974,900
1.83%
2,902,700
0.66%
08/15/2017
Nikko Asset Management Co., Ltd.
10,296,548
1.45%
161,548
0.24%
09/03/2018
Daiwa Asset Management Co. Ltd.
9,712,400
1.37%
-94,800
0.43%
07/31/2018
Norges Bank Investment Management
9,473,089
1.34%
-51,992
0.05%
12/31/2017
| Address |
Daiichi Sankyo Head Office Bldg, A&B
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.daiichisankyo.co.jp |
| Updated |
07/08/2019 |
| Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. |
